Welcome to our dedicated page for RUSHNET news (Ticker: RSHN), a resource for investors and traders seeking the latest updates and insights on RUSHNET stock.
RushNet Inc (RSHN) is a dynamic company that has recently undergone significant changes in its leadership and business focus. With the appointment of Michael Cunha as the new Chairman and CEO, RushNet is transitioning out of the lab business and venturing into new sectors. Michael Cunha brings over three decades of experience in manufacturing, finance, and executive leadership to the company, having spearheaded successful ventures in the past.
RushNet recently signed an exclusive licensing agreement with Royal Caridea LLC, granting them access to innovative aquaculture technology for the United States and Canadian markets. The Royal Caridea technology platform enables individuals to cultivate and harvest aquaculture species like shrimp with low production costs and high scalability. This strategic partnership is poised to disrupt the aquaculture industry and revolutionize shrimp production in North America.
With a commitment to environmental stewardship and sustainability, RushNet is focused on introducing groundbreaking technologies that address the pressing challenges facing various sectors. The company's recent collaborations and initiatives underscore its dedication to innovation and growth, setting the stage for a promising future.
RushNet, Inc (OTC PINK:RSHN) announced the appointment of Aimee Matlock as the Director of Sales and Marketing for its subsidiary heliosDX. With 19 years of experience, including a successful tenure at EMSI, Matlock will start on August 2, 2021. Her responsibilities include launching a national sales campaign utilizing various media platforms. heliosDX is a National Clinical Reference Laboratory with services such as urine drug testing and genetic testing, operating in 44 states and aiming to expand its reach and capabilities.
RushNet, Inc (OTC PINK:RSHN) has announced the appointment of Yann Gerville-Reache as the Chief Operations Officer for its subsidiary heliosDX, effective August 2, 2021. Gerville-Reache brings over 20 years of experience in various sectors including Transportation and Energy, with a strong background in lean manufacturing and project management. His role will focus on enhancing operational efficiency and supporting sales and customer experience initiatives at heliosDX, a clinical reference laboratory expanding its capabilities across 44 states.
RushNet, Inc. (OTC PINK:RSHN) announces a comprehensive six-month Nationwide Media Blitz in partnership with FMW Media Works, reaching over 300 million homes. The campaign includes 660 national commercial spots across major networks like Fox News and CNN, along with digital billboards in New York. CEO Ashley Sweat highlights this initiative as pivotal for building the heliosDX brand, aiming for significant revenue growth. The company anticipates annual revenues of $25 million post-acquisition of a private lab, enhancing shareholder value.
RushNet, Inc (OTC PINK:RSHN) announced a 6-part interview series with FMW Media's New to The Street/Newsmax, reaching over 300 million homes via networks including Fox Business and Bloomberg. This coincides with their acquisition of heliosDX, a National Diagnostics Laboratory, which enhances growth potential. The company plans to launch a National Sales Campaign using Verb Technology Company, Inc. (Nasdaq:VERB)'s innovative marketing platform to reduce costs associated with traditional sales. Broadcasts start July 31, 2021.
RushNet, Inc. (OTC PINK:RSHN) announces Scott Wakeman as the first board member for heliosDX following its split-off from RushNet. Wakeman, an experienced executive with a background in marketing and operations, is expected to enhance heliosDX's branding and sales strategies. The company has completed its Phase One rebranding and is preparing for a national sales campaign aimed at increasing market presence. Additionally, RushNet shareholders will receive a dividend of heliosDX shares and can convert qualified RushNet shares post-split-off, potentially enhancing value.
RushNet, Inc (OTC PINK:RSHN) has successfully completed the acquisition of heliosDX, effective July 1, 2021. This National Clinical Reference Laboratory reported annual revenues of approximately $4.29 million in 2020, with 2021 projections reaching $6 million. The acquisition is expected to elevate annual revenues beyond $16 million, with an ambitious target of exceeding $50 million within two years. heliosDX aims to expand its offerings and improve its market position following the integration of a privately held laboratory, enhancing its specimen capacity and potential growth in infectious disease testing.
RushNet, Inc. (OTC PINK:RSHN) has provided an update on its roadmap, highlighting the acquisition of heliosDX and the enhancement of spinoff dividends. Key developments include the completion of disclosures, a record-breaking financial update, and the cancellation of a reverse stock split. RushNet shareholders are set to receive shares of heliosDX and have the exclusive right to purchase additional shares at a significant discount. The recent Binding Letter of Intent with a private lab could potentially triple heliosDX's annual revenue, bolstering future growth prospects.
RushNet, Inc. (OTC PINK:RSHN) announced the closing of its transaction with heliosDX, pending compliance with OTCMarkets audit requirements. The company plans to spin off heliosDX, rewarding shareholders with a dividend of up to 12 shares per 1000 shares owned. Following this, RushNet will also spin off, with further dividends to be detailed soon. Additionally, RushNet is set to acquire Grandeza Healthcare Consultants, projected to generate over $1,000,000 in revenue this year. This strategy aims to maximize shareholder value through operational synergies.
RushNet, Inc (OTC PINK:RSHN) announces the launch of a National Sales Campaign in partnership with heliosDX using Verb Technology Company, Inc. (Nasdaq:VERB) platforms, verbTEAMS and verbLIVE. This campaign aims to enhance brand visibility and sales efficiency. The interactive technology facilitates virtual sales meetings and allows for accessibility to marketing materials during calls, potentially increasing revenues. HeliosDX has shown significant growth over the past two years and is contracted in 44 states, seeking further expansion.
FAQ
What is the current stock price of RUSHNET (RSHN)?
What is the market cap of RUSHNET (RSHN)?
Who is the new Chairman and CEO of RushNet Inc?
What recent changes have occurred within RushNet Inc?
What strategic partnership has RushNet Inc entered into recently?
What are the key features of the Royal Caridea technology platform?